NRX Pharmaceuticals, Inc. — 4/A Filings
4 4/A filings on record
This page lists all 4/A filings submitted to the SEC by NRX Pharmaceuticals, Inc. (NRXPW), sorted by most recent first. Each row links to the full filing on EdgarLookup. NRX Pharmaceuticals, Inc. has filed 4 4/A documents with the SEC since 2017. To view all SEC filings by NRX Pharmaceuticals, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
25-NSE
3
4
4/A
424B3
424B4
424B5
424B7
425
5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
D
DEF 14A
DEFA14A
EFFECT
NT 10-K
NT 10-Q
POS AM
POS EX
PRE 14A
PRER14A
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4/A | — | 0001415889-22-012650 | Dec 19, 2022 | Nov 25, 2022 |
| 4/A | OWNERSHIP DOCUMENT | 0000950142-22-003250 | Nov 23, 2022 | Oct 21, 2022 |
| 4/A | OWNERSHIP DOCUMENT | 0000921895-22-001874 | Jun 2, 2022 | Jun 1, 2022 |
| 4/A | PRIMARY DOCUMENT | 0001094891-21-000243 | Jun 4, 2021 | May 24, 2021 |